Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRWS Holdings Regulatory News (RWS)

Share Price Information for RWS Holdings (RWS)

Share Price is delayed by 15 minutes
Get Live Data
103.20    -1.30 (-1.24%)
Bid:
102.70
Ask:
103.40
Spread: 0.70 (0.682%)
Market Cap: £383.04m
RWS Live PriceLast checked at - London Stock Exchange

Intraday RWS Holdings Share Chart

Director/PDMR Shareholding

9 Jun 2021 13:00

RNS Number : 3549B
RWS Holdings PLC
09 June 2021
Β 

For immediate release 9 June 2021

Β 

Β RWS Holdings plc

Exercise of options, Share Option Scheme and Grant of Options

RWS Holdings plc ("RWS" or "the Company"), the world's leading provider of technology-enabled language, content management and intellectual property support services, announces the issue of shares following the exercise by an employee of options and the granting of share options under the RWS Share Option Plan 2019 ("the Plan"). The plan is designed to promote the retention, recruitment and incentivization of the Company's leadership team.

Issue of shares

484 new ordinary shares of 1 pence each in RWS ("RWS Shares") have been issued today in order to satisfy the exercise of options by an employee under the RWS Holdings 2019 Sharesave Scheme at 413 pence per share. Admission is expected to take place at 8.00am on 15 June 2021.

Following the exercise of options, the Company's issued share capital comprises 389,241,616 RWS Shares. RWS has no Shares held in treasury. The above figure includes 55,896 RWS Shares that are held by the RWS Holdings plc Employee Benefit Trust in order to satisfy awards under the Company's employee share schemes. Therefore shareholders may use the figure of 389,185,720 as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, RWS under the Financial Conduct Authority's Disclosure and Transparency Rules.

Granting of share options

On 9 June 2021, the RWS Board approved the following grant of options over 34,192 RWS Shares at an exercise price of 613 pence (being the closing mid-market price on 8 June 2021, the business day preceding the date of grant), representing approximately 0.01 per cent of the Company's issued share capital.

Name

Position

Grant of options

Neil Simpkin

President, RWS IP Services

34,192

Β 

These options will normally vest on the third anniversary of the grant date, subject to the rules of the Plan, continued employment and achievement of performance conditions. The performance conditions applicable to the options are based on the Company achieving EPS targets, each option being split into three tranches, each subject to an EPS target for a reporting year set annually in advance by RWS's Remuneration Committee.

Vested options are then subject to a two-year holding period and will be exercisable on the fifth anniversary of the grant date and will lapse on the tenth anniversary of the grant date. All options are subject to defined malus and clawback provisions.

The information set out below is provided in accordance with the requirements of Article 19(8) of the Market Abuse Regulation (EU) No 596/2014,

Β 

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

Neil Simpkin

2.

Reason for the notification

a.

Position/status

President, RWS IP Services

b.

Initial notification

/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

RWS Holdings plc

b.

LEI

213800YGBGTTSKUVK111

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument, type

of instrument

Identification code

Ordinary shares of 1p each

GB00BVFCZV34

b.

Nature of the transaction

1) Grant of share options over ordinary shares with an exercise price of 613 pence each

Β 

Β 

Β 

c.

Price(s) and volume(s)

Β 

Β 

Exercise Price(s)

Β 

Volume(s)

Option Grant

Nil

Β 34,192

Β 

Β 

Β 

Β 

d.

Aggregated information

Β·Aggregated

volume

Β·Price

Β 

Β 

Β 

Price(s)

Β 

Volume(s)

Option Grant

Nil

34,192

Β 

Β 

Β 

Β 

e.

Date of the transaction

Β 9 June 2021

f.

Place of the transaction

Outside a trading venue

Β 

Β 

Β 

For further information, please visit: www.rws.com.

RWS Holdings plc

Andrew Brode, Chairman

Richard Thompson, Chief Executive Officer

Des Glass, Chief Financial Officer

Β 

01753 480796

Β 

MHP (Financial PR advisor)

Katie Hunt / Simon Hockridge

rws@mhpc.com

0203 128 8100

Β 

Numis (Nomad & Joint Broker)

Stuart Skinner / Kevin Cruickshank/Will Baunton

Β 

Berenberg (Joint Broker)

Ben Wright/Toby Flaux/ Alix Mecklenburg-Solodkoff

Β 

0207 260 1000

Β 

Β 

0203 207 7800

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
DSHDKCBQDBKDBAK
Date   Source Headline
2nd Jun 202610:17 amRNSHolding(s) in Company
1st Jun 20267:00 amRNSTotal Voting Rights
5th May 202612:23 pmRNSUpdate re Agreement to acquire Obviously Group Ltd
5th May 20267:00 amRNSAgreement in principle to acquire Obviously Group
1st May 20267:00 amRNSTotal Voting Rights
28th Apr 202612:10 pmRNSHolding(s) in Company
27th Apr 20262:48 pmRNSHolding(s) in Company
23rd Apr 20267:00 amRNSTrading Statement
1st Apr 20267:00 amRNSTotal Voting Rights
26th Mar 20263:41 pmRNSDirector/PDMR Shareholding
25th Mar 20269:15 amRNS-RRWS launches Language Weaver Pro
25th Mar 20267:00 amRNSIssue of Equity and Total Voting Rights
10th Mar 20264:40 pmRNSHolding(s) in Company
10th Mar 20264:40 pmRNSHolding(s) in Company
4th Mar 20269:37 amRNSDirector/PDMR Shareholding
2nd Mar 20267:00 amRNSTotal Voting Rights
12th Feb 202611:45 amRNSDirector/PDMR Shareholding
11th Feb 202611:44 amRNSResult of AGM
11th Feb 20267:00 amRNSAGM Statement
10th Feb 20262:00 pmRNSHolding(s) in Company
6th Feb 202612:30 pmRNSDirector/PDMR Shareholding
2nd Feb 20267:00 amRNSTotal Voting Rights
30th Jan 20263:06 pmRNSHolding(s) in Company
28th Jan 20263:24 pmRNSDirector/PDMR Shareholding
28th Jan 20263:19 pmRNSDirector/PDMR Shareholding
23rd Jan 20261:00 pmRNSDirector/PDMR Shareholding
23rd Jan 20261:00 pmRNSDirector/PDMR Shareholding
23rd Jan 20269:00 amRNSOption Exercise, Admission and Total Voting Rights
23rd Jan 20267:00 amRNSHolding(s) in Company
14th Jan 20267:00 amRNSHolding(s) in Company
8th Jan 20269:00 amRNSPublication of Annual Report and Notice of AGM
2nd Jan 20264:51 pmRNSHolding(s) in Company
2nd Jan 20267:00 amRNSTotal Voting Rights
2nd Jan 20267:00 amRNSTotal Voting Rights
19th Dec 20257:00 amRNSHolding(s) in Company
19th Dec 20257:00 amRNSHolding(s) in Company
12th Dec 20253:53 pmRNSHolding(s) in Company
11th Dec 20257:01 amRNSDirectorate change
11th Dec 20257:00 amRNSFinal Results
1st Dec 20257:00 amRNSTotal Voting Rights
11th Nov 20258:00 amRNSHolding(s) in Company
7th Nov 20259:00 amRNSHolding(s) in Company
3rd Nov 20257:00 amRNSTotal Voting Rights
31st Oct 20259:00 amRNSHolding(s) in Company
28th Oct 20257:00 amRNSTrading Statement
20th Oct 20253:06 pmRNSHolding(s) in Company
20th Oct 20259:05 amRNS-RHead of Media & Entertainment appointment
15th Oct 20257:00 amRNSDirectorate Change
3rd Oct 20257:00 amRNSDirectorate Change
2nd Oct 202511:38 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.